Revista de Osteoporosis y Metabolismo Mineral

Scope & Guideline

Illuminating the Path to Better Bone Health

Introduction

Delve into the academic richness of Revista de Osteoporosis y Metabolismo Mineral with our guidelines, detailing its aims and scope. Our resource identifies emerging and trending topics paving the way for new academic progress. We also provide insights into declining or waning topics, helping you stay informed about changing research landscapes. Evaluate highly cited topics and recent publications within these guidelines to align your work with influential scholarly trends.
LanguageMulti-Language
ISSN1889-836x
PublisherSOC ESPANOLA INVESTIGACION OSEA & METABOLISMO MINERAL
Support Open AccessYes
CountrySpain
TypeJournal
Convergefrom 2014 to 2024
AbbreviationREV OSTEOPOR METAB M / Rev. Osteoporos. Metab. Min.
Frequency4 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressPASEO CASTELLANA, 135, 7A PLANTA, MADRID 28046, SPAIN

Aims and Scopes

The 'Revista de Osteoporosis y Metabolismo Mineral' focuses on advancing the understanding of osteoporosis and related metabolic bone diseases through comprehensive research and clinical studies. The journal encourages interdisciplinary collaboration and aims to disseminate knowledge that aids in the prevention, diagnosis, and treatment of these conditions.
  1. Osteoporosis Mechanisms and Pathophysiology:
    Research exploring the biological mechanisms underlying osteoporosis, including cellular and molecular pathways, hormonal influences, and genetic predispositions.
  2. Clinical Management and Treatment Strategies:
    Publications that provide insights into the efficacy, safety, and long-term outcomes of various therapeutic approaches for osteoporosis, including pharmacological treatments and lifestyle interventions.
  3. Risk Assessment and Predictive Tools:
    Studies focusing on the development and validation of risk assessment tools, such as the FRAX tool, to better predict fracture risks in diverse populations.
  4. Impact of Comorbidities on Bone Health:
    Investigations into how various comorbid conditions, such as diabetes and autoimmune disorders, influence bone metabolism and osteoporosis progression.
  5. Innovative Research Methodologies:
    Utilization of advanced research methods, including genetic studies, imaging techniques, and clinical trials, to explore new dimensions in osteoporosis research.
Recent publications in the 'Revista de Osteoporosis y Metabolismo Mineral' indicate a dynamic evolution of research themes, highlighting emerging areas of interest and growing trends within the field of osteoporosis and metabolic bone diseases.
  1. Personalized Medicine and Genetic Factors:
    An increasing focus on polygenic risk scores and genetic predispositions to osteoporosis signifies a shift towards personalized medicine, where treatments can be tailored based on individual genetic profiles.
  2. Role of Hormones in Bone Health:
    Research investigating the impact of sex hormones and other endocrine factors on bone metabolism is gaining traction, reflecting a deeper understanding of the hormonal regulation of bone health.
  3. Innovative Therapeutics and Treatment Approaches:
    The emergence of new anabolic drugs and treatment strategies for osteoporosis, such as abaloparatide and romosozumab, showcases a trend towards exploring novel therapeutic options.
  4. Multidisciplinary Approaches in Osteoporosis Management:
    The integration of multidisciplinary strategies, including collaboration among various healthcare professionals to manage osteoporosis, is becoming increasingly prevalent in research.
  5. Impact of Lifestyle and Comorbidities on Osteoporosis:
    There is a growing recognition of how lifestyle factors, such as diet and exercise, along with comorbid conditions, influence bone health, which is reflected in recent studies.

Declining or Waning

While the journal has consistently focused on various aspects of osteoporosis and metabolic bone diseases, certain themes have seen a reduction in publication frequency or focus over the years. This decline may reflect shifting research interests or advancements in the field.
  1. Basic Science Studies:
    There appears to be a diminishing emphasis on purely basic science research without direct clinical applications, as the journal increasingly prioritizes studies that translate findings into clinical practice.
  2. Historical Perspectives on Osteoporosis:
    Papers providing retrospective analyses or historical accounts of osteoporosis management have become less frequent, indicating a shift towards contemporary and forward-looking research.
  3. Nutritional Studies Unrelated to Bone Health:
    Research focusing solely on general nutritional studies without a clear link to bone health or osteoporosis has decreased, as the journal aims to concentrate on more relevant and impactful findings.
  4. Single-Country Studies:
    There is a noticeable reduction in studies that focus exclusively on osteoporosis in a single country, suggesting a trend towards more comparative and international research that can provide broader insights.
  5. Pharmacological Studies on Older Treatments:
    Publications centered around older osteoporosis treatments have waned, as the field is moving towards exploring newer therapeutic options and innovative treatment strategies.

Similar Journals

Austrian Journal of Clinical Endocrinology and Metabolism

Exploring innovative solutions for endocrine disorders.
Publisher: SPRINGER WIENISSN: 1998-7773Frequency: 4 issues/year

Austrian Journal of Clinical Endocrinology and Metabolism, published by SPRINGER WIEN, serves as a pivotal platform for the dissemination of research in the field of endocrinology, diabetes, and metabolism. With its ISSN 1998-7773 and E-ISSN 1998-7781, this journal has been contributing valuable insights to the field since its inception in 2010. Although it currently holds a Q4 ranking in the category of Endocrinology, Diabetes and Metabolism, it is committed to improving its impact factor by showcasing high-quality, peer-reviewed articles that reflect contemporary challenges and innovations in clinical endocrinology. Located in Vienna, Austria, the journal aims to provide researchers, healthcare professionals, and students with access to the latest findings and clinical practices that advance understanding and treatment of endocrine disorders. Researchers interested in submitting their work will find a supportive environment that embraces both experimental and clinical approaches. The Austrian Journal of Clinical Endocrinology and Metabolism is poised to become a valuable resource for those dedicated to improving health outcomes in metabolic disorders.

International Journal of Endocrinology

Elevating the discourse in endocrinology with cutting-edge research.
Publisher: HINDAWI LTDISSN: 1687-8337Frequency:

The International Journal of Endocrinology is a premier peer-reviewed journal, published by HINDAWI LTD, focusing on the rapidly evolving fields of endocrinology, diabetes, and metabolism. Since its establishment in 2009, the journal has embraced an Open Access model, ensuring that cutting-edge research is accessible to a global audience without barriers. With an impressive Scopus rank placing it within the top quartiles of related fields, it ranks #103 in Endocrinology, Diabetes and Metabolism, showcasing its significant contribution to the ongoing discourse in these areas. The journal's scope includes original research, reviews, and clinical studies that advance understanding and treatment strategies for endocrine disorders. By bridging the gap between research, clinical practice, and patient care, the International Journal of Endocrinology serves as an essential resource for researchers, practitioners, and students dedicated to the field of endocrinology. Addressed from its headquarters in the United States, this journal not only contributes to academic advancement but also fosters international collaboration in addressing key challenges in endocrinology.

INTERNATIONAL JOURNAL OF OBESITY

Connecting Experts to Tackle Obesity Challenges
Publisher: SPRINGERNATUREISSN: 0307-0565Frequency: 12 issues/year

INTERNATIONAL JOURNAL OF OBESITY, published by SpringerNature, stands as a premier multidisciplinary platform for research in the fields of Endocrinology, Diabetes and Metabolism, Nutrition and Dietetics, as well as Miscellaneous Medicine. With a remarkable impact, the journal is consistently positioned in the Q1 category across these critical areas, underscoring its significance in advancing the understanding of obesity and its related health outcomes. Established in 1977 and covering a broad spectrum of studies until 2024, it boasts a notable Scopus Rank reflecting its influential contributions to the scientific community, including a rank of 14 out of 140 in Nutrition and Dietetics. The INTERNATIONAL JOURNAL OF OBESITY is not just a repository of knowledge but a vital resource for researchers, clinicians, and students aiming to explore the complexities of obesity and develop evidence-based interventions. Despite not being an open-access journal, its rigorous peer-reviewed articles remain accessible to those within academic institutions, facilitating an essential dialogue among professionals dedicated to this critical global health issue.

EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES

Exploring Innovations in Endocrine Science
Publisher: GEORG THIEME VERLAG KGISSN: 0947-7349Frequency: 10 issues/year

EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES is a distinguished journal published by GEORG THIEME VERLAG KG, dedicated to advancing research and understanding in the fields of endocrinology, diabetes, and metabolism. With an ISSN of 0947-7349 and an E-ISSN of 1439-3646, this journal serves as a critical platform for disseminating high-quality research findings, reviews, and clinical studies from 1983 to 2024. The journal holds an impactful position within its respective categories, notably achieving Q3 in Endocrinology and Diabetes and Metabolism, and Q2 in Internal Medicine as per the 2023 category quartiles. Additionally, it ranks in the 57th and 46th percentiles in the Scopus rankings for Internal Medicine and Endocrinology, Diabetes and Metabolism, respectively. Though not an open-access publication, the journal caters to a global audience of researchers, professionals, and students, facilitating knowledge exchange and fostering collaboration within this vital area of medical science.

OSTEOPOROSIS INTERNATIONAL

Transforming Research into Clinical Practice
Publisher: SPRINGER LONDON LTDISSN: 0937-941XFrequency: 12 issues/year

OSTEOPOROSIS INTERNATIONAL, published by SPRINGER LONDON LTD, stands at the forefront of research in the field of bone health and metabolic disorders, specifically focusing on osteoporosis and related conditions. With an ISSN of 0937-941X and impressive ranking in the Q1 category of both Endocrinology, Diabetes and Metabolism, and Medicine (miscellaneous) for 2023, this journal ranks 47th out of 244 in its category, placing it solidly within the top 20% of its field, according to Scopus metrics. The journal, active since 1990, aims to foster a deep understanding of osteoporosis through high-quality research articles, reviews, and clinical insights that are pivotal for healthcare professionals, researchers, and students alike. Although it does not offer open access, users can expect rigorous peer-reviewed content that significantly contributes to the advancement of knowledge in osteoporosis prevention, diagnosis, and treatment. With a dedicated readership and a commitment to excellence, OSTEOPOROSIS INTERNATIONAL plays a vital role in shaping the future of bone health research.

Translational Psychiatry

Connecting neuroscience and clinical practice for transformative outcomes.
Publisher: SPRINGERNATUREISSN: 2158-3188Frequency: 1 issue/year

Translational Psychiatry, an esteemed journal published by SpringerNature, is at the forefront of research in the fields of biological psychiatry, neuroscience, and mental health. With an impressive Q1 category ranking in Biological Psychiatry, Cellular and Molecular Neuroscience, and Psychiatry and Mental Health, the journal fosters high-quality scholarly work that informs clinical practices and guides future research directions. Since its inception in 2011, Translational Psychiatry has embraced the Open Access model, ensuring that groundbreaking findings are easily accessible to all, promoting collaboration and innovation within the global scientific community. With a solid ranking in Scopus—particularly at #33 out of 567 in Psychiatry and Mental Health and #6 out of 51 in Biological Psychiatry—this journal plays a critical role in advancing our understanding of mental health disorders, bridging the gap between bench science and clinical application. As it continues evolving through its converged years from 2011 to 2024, Translational Psychiatry remains an essential resource for researchers, healthcare professionals, and students dedicated to improving mental health outcomes.

Sleep and Biological Rhythms

Exploring the Intricacies of Sleep and Health
Publisher: SPRINGER JAPAN KKISSN: 1446-9235Frequency: 4 issues/year

Sleep and Biological Rhythms is a pivotal scholarly journal published by Springer Japan KK, focusing on the intricate relationships between sleep patterns and biological rhythms across various biological and psychological paradigms. Since its inception in 2003, this journal has consistently presented high-quality original research and comprehensive reviews that shed light on the multifaceted roles of sleep in health, disease, and behavioral science, making it an essential resource for researchers, professionals, and students in neurology, neuropsychology, and physiology. With an impact factor that places it in the Q3 quartile across several relevant categories, including neurology and physiological psychology, Sleep and Biological Rhythms provides critical insights that help advance our understanding of the physiological mechanisms underpinning sleep and circadian rhythms. While this journal offers a subscription-based model, its commitment to publishing rigorously peer-reviewed content ensures that it remains a trusted reference point for innovators and thought leaders in the fields of neuroscience and medicine. For more information, users are encouraged to access the journal through its dedicated page on the Springer website.

JOURNAL OF BONE AND MINERAL METABOLISM

Exploring the intersections of endocrinology and orthopedics.
Publisher: SPRINGER JAPAN KKISSN: 0914-8779Frequency: 6 issues/year

JOURNAL OF BONE AND MINERAL METABOLISM, published by SPRINGER JAPAN KK, is a leading peer-reviewed journal dedicated to advancing the field of bone and mineral research since its establishment in 1988. With ISSN 0914-8779 and E-ISSN 1435-5604, this esteemed journal offers a platform for high-quality research that intersects Endocrinology, Diabetes and Metabolism, Orthopedics and Sports Medicine, and related disciplines. Recognized for its rigorous standards, it holds a commendable Q2 ranking in multiple categories, reflecting its broad influence and relevance in contemporary medical research. Researchers and practitioners alike benefit from its evidence-based articles and insights, which contribute significantly to our understanding of metabolic bone diseases and mineral homeostasis. Although not an open-access journal, it still provides essential information and advancements crucial for professionals and scholars dedicated to improving clinical outcomes and enhancing patient care in these vital areas. To learn more, please explore the journal's archives and latest publications.

International Journal of Endocrinology and Metabolism

Exploring Innovations in Endocrinology and Metabolism
Publisher: BRIEFLANDISSN: 1726-913XFrequency: 4 issues/year

The International Journal of Endocrinology and Metabolism is a leading peer-reviewed publication dedicated to advancing knowledge and research in the fields of endocrinology, diabetes, and metabolism. Published by BRIEFLAND in the Netherlands, this journal features original research, comprehensive reviews, and insightful clinical studies that explore the multifaceted aspects of hormonal disorders and metabolic conditions. With an impact factor that places it in the Q3 quartile category for 2023, the journal serves as a critical resource for academics and practitioners aiming to stay at the forefront of this dynamic field. Spanning from 2010 to 2024, the journal offers an enriching platform for innovative ideas and practices, fostering collaboration among scholars and healthcare professionals alike. Although not open access, the content is meticulously curated to ensure high-quality scientific discourse, positioning the International Journal of Endocrinology and Metabolism as an essential reference for those dedicated to improving health outcomes related to endocrine and metabolic disorders.

Sleep and Breathing

Bridging the Gap Between Sleep Science and Clinical Practice
Publisher: SPRINGER HEIDELBERGISSN: 1520-9512Frequency: 4 issues/year

Sleep and Breathing is a leading international journal published by SPRINGER HEIDELBERG, specializing in the fields of neurology and otorhinolaryngology. Since its inception in 1996, the journal has established itself as a pivotal resource for clinicians and researchers exploring the complex interactions between sleep and respiratory health. With an impressive Q2 ranking in Neurology (clinical) and a Q1 ranking in Otorhinolaryngology, it serves a diverse readership, offering a rich repository of original research, reviews, and clinical studies that address critical challenges in sleep medicine. The journal currently boasts a robust Scopus ranking, placing it among the top-tier publications in both specialties (Rank #16/123 in Otorhinolaryngology and Rank #140/400 in Clinical Neurology). While access options are limited, the high impact factor underscores its significance in shaping contemporary research dialogue. As such, Sleep and Breathing continues to be an essential platform for advancing knowledge and fostering collaboration within the nexus of sleep science and respiratory health.